Homology modeling of wild-type, d516v, and h526l mycobacterium tuberculosis rna polymerase and their molecular docking study with inhibitors

Journal of Biomolecular Structure and Dynamics

Volumn 25, Issue 4, 2008, Pages 373-376

  Josa, Daniela ^a   da Cunha, Elaine F F ^a   Ramalho, Teodorico C ^a   Souza, Thais C S ^a   Caetano, Melissa S ^a  

^a FEDERAL UNIVERSITY OF LAVRAS   (Brazil)

Author keywords

Docking; Homology modeling; Mycobacterium tuberculosis RNA polymerase; Rifamycins

Indexed keywords

BACTERIAL ENZYME; LIGAND; RIFABUTIN; RIFALAZIL; RIFAMPICIN; RIFAPENTINE; RNA POLYMERASE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; HYDROGEN BOND; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOLECULAR MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 38349188416     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2008.10507185     Document Type: Article

References (37)

1. Barluenga, J., Aznar, F., García, A. B., Cabal, M. P., Palácios, J. J., and Menéndez, M. A., 2006. Bioorg Med Chem Lett, 16:5717–5722.
2. da Cunha, E. F.F., Ramalho, T. C., Mala, E. R., and Alencastro, R. B., 2005. Expert Opinion on Therapeutic Patents, 15:967–986.
3. Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., and Darst, S. A., 2001. Cell, 104:901–912.
4. Moghazeh, S. L., Pan, X. I., Arain, T., Stover, C. K., Musser, J. M., and Kreiswirth, B. N., 1996. Ant Agents Chemother, 40:2665–2657.
5. Yang, B., Koga, H., Ohno, H., Ogawa, K., Fukuda, M., Hirakata, Y., Maesaki, S., Tomono, K., Tashiro, T., and Kohno, S., 1998. J A C, 42:621–628.
6. Kim, B. J., Lee, S. H., Lyu, M. A., Kim, S. J., Bai, G. H., Kim, S. J., Chae, G. T., Kim, E. I., Cha, C. Y., and Kook, Y. H., 1999. J Clin Microbiol, 37:1714–1720.
7. Ahmad, S., Araj, G. F., Akbar, P. K., Fares, E., Chugh, T. D., and Mustafa, A. S., 2000. Diagn Microb Infect Disease, 38:227–232.
8. Heep, M., Brandstätter, B., Rieger, U., Lehn, N., Richter, E., Rüsch-Gerdes, S., and Niemann, S., 2001. J Clin Microbiol, 39:107–110.
9. Zhang, Y., 2005. Annu Rev Pharmacol Toxicol, 45:529–564.
10. Williams, D. L., Spring, L., Collins, L., Miller, L. P., Heifets, L. B., Gangadharam, P. R. J., and Gillis, T. P., 1998. Antimicrob Agents Chemother, 42:1853–1857.
11. Kasik, J. E., and Monick, M., 1981. Antimicrob Agents Chemother, 19:134–138.
12. Saito, H., Tomioka, H., Sato, K., Emori, M., Yamane, T., Yamashita, K., Hosoe, K., and Hi-daka, T., 1991. Antimicrob Agents Chemother, 35:542–547.
13. Bacchi, A., and Pellizzi, G., 1998. J Med Chem, 41:2319–2332.
14. Peitsch, M. C., 1995. Bio/Technology, 13:658–660.
15. Peitsch, M. C., 1996. Biochem Soc Trans, 24:274–276.
16. Peitsch, M. C., and Guexjrnl, N., 1997. Electrophoresis, 18:2714–2723.
17. Schwede, T., Kopp, J., Guex, N., and Peitsch, Mc. 2003. Nucleic Acids Research, 31:3381–3385.
18. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E., 2000. Nucleic Acids Research, 28:235–242.
19. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J., 1990. J Mol Biol, 215:403–410.
20. Artsimovitch, I., Vassylyeva, M. N., Svetlov, D., Svetlov, V., Perederina, A., Igarashi, N., Matsugaki, N., Wakatsuki, S., Tahirov, T. H., and Vassylyev, D. G., 2005. Cell, 122:351–363.
21. http://www.ch.embnet.org/software/ClustalW.html
22. http://biotech.ebi.ac.uk:8400/
23. Vriend, G., 1990. J Mol Graph, 8:52–57.
24. Guex, N., Diemand, A., Peitsch, M. C., and Schwede, T., GlaxoSmithKline R&D & the Swiss Institute of Bioinformatics.
25. http://www.molegro.com
26. Michalewicz, Z., 1992. Genetic Algorithms + Data Structures = Evolution Programs. SpringerVerlag:Berlin.
27. Michalewicz, Z., and Fogel, D. B., 2000. How to Solve It:Modern Heuristics. Springer-Verlag:Berlin.
28. Thomsen, R., and Christensen, M. H., 2006. J Med Chem, 49:3315–3321.
29. da Cunha, E. F.F., Ramalho, T. C., Mala, E. R., Alencastro, R. B., and Taft, C. A., 2006. Letters in Drug Design & Discovery, 3:17–28.
30. Muri, E. M. F., Gomes, M., Albuquerque, M. G., da Cunha, E. F.F., de Alencastro, R. B., Williamson, J. S., and Antunes, O. A. C., 2005. Amino Acids, 28:413–419.
31. Muri, E. M. F., Gomes, M., Albuquerque, M. G., da Cunha, E. F.F., de Alencastro, R. B., Williamson, J. S., and Antunes, O. A. C., 2004. Amino Acids, 27:153–159.
32. Vriend, G., 1990. J Mol Graph, 8:52–56.
33. Hooft, R. W. W., Vriend, G., Sander, C., and Abola, E. E., 1996. Nature, 381:272–272.
34. Rodriguez, R., Chinea, G., Lopez, N., Pons, T., and Vriend, G., 1998. CABIOS, 14:523–528.
35. Ramalho, T. C., Martins, T. L. C., Borges, L. E. P., and Figueroa-Villar, J. D., 2003. Int J Quant Chem, 95:267–273.
36. da Cunha, E. F.F., Ramalho, T. C., de Alencastro, R. B., and Maia, E. R., 2004. J Biom Struct Dyn, 22:119–130.
37. da Cunha, E. F.F., Ramalho, T. C., Maia, E. R., and de Alencastro, R. B., 2005. Expert Opinion on Therapeutic Patents, 15:967–986.